Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05259995 · ClinicalTrials.gov registry record · Phase 1
Sustained Acoustic Medicine Ultrasound Diathermy Clinical Performance
A Phase 1 study, sponsored by ZetrOZ.
- Completed
- Registry status
- Phase 1
- Development phase
- 54
- Enrollment target
NCT05259995: Completed Phase 1 study, sponsored by ZetrOZ.
NCT05259995 is a Phase 1 study that has completed, run by ZetrOZ. The registered enrollment target is 54 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (10% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05259995, a Phase 1 study, has completed, sponsored by ZetrOZ.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to measure diathermy performance of Sustained Acoustic Medicine Devices with commercially available ultrasound gel coupling patches.
Primary Outcome
Temperature Measurement On Body (Degrees Centigrade)
Interventions
- DEVICE Sustained Acoustic Medicine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2022-02-21 |
| Est. Completion | 2022-06-30 |
| Phase | Phase 1 |
What the finished NCT05259995 record still lists
NCT05259995 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (10% lower).
The record links to 0 conditions, and to 1 intervention - of which Sustained Acoustic Medicine is the first listed.
NCT05259995 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05259995 about?
NCT05259995 is a clinical study titled "Sustained Acoustic Medicine Ultrasound Diathermy Clinical Performance". The purpose of this study is to measure diathermy performance of Sustained Acoustic Medicine Devices with commercially available ultrasound gel coupling patches.
What is the current status of trial NCT05259995?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 54 participants. The study started on 2022-02-21. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT05259995?
The interventions under investigation include: Sustained Acoustic Medicine (DEVICE).
Who is sponsoring clinical trial NCT05259995?
This trial is sponsored by ZetrOZ, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05259995's enrollment target sits among peer trials
54 931st of 2000 higher than 1,053 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI